Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.

Goessens L, Colombel JF, Outtier A, Ferrante M, Sabino J, Judge C, Saeidi R, Rabbitt L, Armuzzi A, Domenech E, Michalopoulos G, Cremer A, García-Alonso FJ, Molnar T, Karmiris K, Gecse K, Van Oostrom J, Löwenberg M, Farkas K, Atreya R, Ribaldone DG, Selinger C, Hoentjen F, Bihin B, Sebastian S, European COMBIO study group, Rahier JF

Open source

DOI
10.1002/ueg2.12170
Published
2021 Dec
Container
United European gastroenterology journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ueg2.12170,
  title = {Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.},
  author = {Goessens L and Colombel JF and Outtier A and Ferrante M and Sabino J and Judge C and Saeidi R and Rabbitt L and Armuzzi A and Domenech E and Michalopoulos G and Cremer A and García-Alonso FJ and Molnar T and Karmiris K and Gecse K and Van Oostrom J and Löwenberg M and Farkas K and Atreya R and Ribaldone DG and Selinger C and Hoentjen F and Bihin B and Sebastian S and European COMBIO study group and Rahier JF},
  year = {2021},
  journal = {United European gastroenterology journal},
  doi = {10.1002/ueg2.12170},
  url = {https://doi.org/10.1002/ueg2.12170}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
AU  - Goessens L
AU  - Colombel JF
AU  - Outtier A
AU  - Ferrante M
AU  - Sabino J
AU  - Judge C
AU  - Saeidi R
AU  - Rabbitt L
AU  - Armuzzi A
AU  - Domenech E
AU  - Michalopoulos G
AU  - Cremer A
AU  - García-Alonso FJ
AU  - Molnar T
AU  - Karmiris K
AU  - Gecse K
AU  - Van Oostrom J
AU  - Löwenberg M
AU  - Farkas K
AU  - Atreya R
AU  - Ribaldone DG
AU  - Selinger C
AU  - Hoentjen F
AU  - Bihin B
AU  - Sebastian S
AU  - European COMBIO study group
AU  - Rahier JF
PY  - 2021
JO  - United European gastroenterology journal
DO  - 10.1002/ueg2.12170
UR  - https://doi.org/10.1002/ueg2.12170
ER  - 

APA

L, G., JF, C., A, O., M, F., J, S., C, J., R, S., L, R., A, A., E, D., G, M., A, C., FJ, G., T, M., K, K., K, G., J, V. O., M, L., K, F., R, A., DG, R., C, S., F, H., B, B., S, S., group, E. C. S., & JF, R. (2021). Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.. United European gastroenterology journal. https://doi.org/10.1002/ueg2.12170

Source records